Who owns Liquidia Corp (LQ)? Elite investor 13F holders

4 tracked elite investors reported holding Liquidia Corp as of 2026-06-30, including Caligan Partners, D.E. Shaw, Renaissance Technologies LLC, Gotham Asset Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

4 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company's lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
Caligan PartnersLIQUIDIA CORPORATIONSHARE2026-06-302026-08-14 00:00:00647319259.00 USD8118892.000000SharesholdOriginal filing
D.E. ShawLIQUIDIA CORPORATIONSHARE2026-06-302026-08-14 00:00:00101074200.00 USD1267706.000000SharesaddOriginal filing
Renaissance Technologies LLCLIQUIDIA CORPORATIONSHARE2026-06-302026-08-13 00:00:0018525505.00 USD232353.000000SharesaddOriginal filing
Gotham Asset ManagementLIQUIDIA CORPORATIONSHARE2026-06-302026-08-14 00:00:002545699.00 USD31929.000000SharesaddOriginal filing
Tudor InvestmentLIQUIDIA CORPORATIONSHARE2026-06-302026-08-14 00:00:000.00 USD0.000000SharesexitedOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown